338 related articles for article (PubMed ID: 15728280)
41. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy.
Mathews VP; Barker PB; Blackband SJ; Chatham JC; Bryan RN
AJR Am J Roentgenol; 1995 Sep; 165(3):633-8. PubMed ID: 7645484
[TBL] [Abstract][Full Text] [Related]
42. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
43. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.
Hansen JM; Thomsen LL; Olesen J; Ashina M
Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512
[TBL] [Abstract][Full Text] [Related]
44. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
45. Familial hemiplegic migraine, nystagmus, and cerebellar atrophy.
Elliott MA; Peroutka SJ; Welch S; May EF
Ann Neurol; 1996 Jan; 39(1):100-6. PubMed ID: 8572654
[TBL] [Abstract][Full Text] [Related]
46. Sporadic hemiplegic migraine and epilepsy associated with CACNA1A gene mutation.
Zangaladze A; Asadi-Pooya AA; Ashkenazi A; Sperling MR
Epilepsy Behav; 2010 Feb; 17(2):293-5. PubMed ID: 20071244
[TBL] [Abstract][Full Text] [Related]
47. Magnetic resonance spectroscopy of the thalamus in essential tremor patients.
Kendi AT; Tan FU; Kendi M; Erdal HH; Tellioglu S
J Neuroimaging; 2005 Oct; 15(4):362-6. PubMed ID: 16254402
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
49. [Molecular genetic findings in migraine].
Østergaard E; Thomsen LL; Russell MB
Ugeskr Laeger; 2001 Nov; 163(45):6260-5. PubMed ID: 11723684
[TBL] [Abstract][Full Text] [Related]
50. Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy.
Brighina E; Bresolin N; Pardi G; Rango M
Pediatr Neurol; 2009 May; 40(5):327-42. PubMed ID: 19380068
[TBL] [Abstract][Full Text] [Related]
51. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
52. 1H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy.
Riederer F; Bittsanský M; Schmidt C; Mlynárik V; Baumgartner C; Moser E; Serles W
NMR Biomed; 2006 Aug; 19(5):544-53. PubMed ID: 16521092
[TBL] [Abstract][Full Text] [Related]
53. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
54. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania.
Malhi GS; Ivanovski B; Wen W; Lagopoulos J; Moss K; Sachdev P
Acta Psychiatr Scand Suppl; 2007; (434):57-66. PubMed ID: 17688464
[TBL] [Abstract][Full Text] [Related]
55. Cerebellar metabolic symmetry in essential tremor studied with 1H magnetic resonance spectroscopic imaging: implications for disease pathology.
Louis ED; Shungu DC; Mao X; Chan S; Jurewicz EC
Mov Disord; 2004 Jun; 19(6):672-7. PubMed ID: 15197706
[TBL] [Abstract][Full Text] [Related]
56. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
57. CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood.
de Vries B; Stam AH; Beker F; van den Maagdenberg AM; Vanmolkot KR; Laan L; Ginjaar IB; Frants RR; Lauffer H; Haan J; Haas JP; Terwindt GM; Ferrari MD
Cephalalgia; 2008 Aug; 28(8):887-91. PubMed ID: 18498393
[TBL] [Abstract][Full Text] [Related]
58. Proton MRS in Kennedy disease: absolute metabolite and macromolecular concentrations.
Mader I; Karitzky J; Klose U; Seeger U; Sperfeld A; Naegele T; Schick F; Ludolph A; Grodd W
J Magn Reson Imaging; 2002 Aug; 16(2):160-7. PubMed ID: 12203763
[TBL] [Abstract][Full Text] [Related]
59. CACNA1A nonsense mutation is associated with basilar-type migraine and episodic ataxia type 2.
Robbins MS; Lipton RB; Laureta EC; Grosberg BM
Headache; 2009 Jul; 49(7):1042-6. PubMed ID: 19486177
[TBL] [Abstract][Full Text] [Related]
60. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
